New mechanisms of action of the novel anticancer agent FL118 have been reported by scientists, as well as new potential therapeutic targets for the agent, a camptothecin analogue.
New mechanisms of action of the novel anticancer agent FL118 have been reported by scientists, as well as new potential therapeutic targets for the agent, a camptothecin analogue.